Is $APUS pump-proof?

Apimeds Pharmaceuticals US, Inc.: trap-risk read from social crowding, price extension, and SEC disclosure flags. Updated 2026-10-23.

$APUS
Apimeds Pharmaceuticals US, Inc.
CLEAR RISK
17
/ 100 trap score
Price and crowd are quiet right now, but there's dilution machinery on file. Quiet isn't the same as clean; a rally here feeds the share printer.
Hype / crowding
13
Run-up / extension
5
Structural risk
38
!“Substantial doubt” (going-concern) language in a filing 2 months ago
🔒 3 more filings flagged on $APUS: see all of them free.
All 4 flags + filing links, free. No spam, unsubscribe anytime.
PumpProof · pumpproof.com
as of 2026-10-23 · not financial advice

The record on $APUS

first scored Jul 14: +244% since
30Jul 14
34Oct 12
24Oct 15
16Oct 16
16Oct 17
17Oct 19
16Oct 21
17Oct 23
Every score we publish is snapshotted the day it runs. Wins and misses stay on the record. Full ledger in the Friday email.
What these filings mean
What a going-concern warning means →Why penny stocks reverse-split →How share dilution works →All the filing explainers →
Check any other ticker free at pumpproof.com

Get the Sunday watchlist before Monday's open

Every Sunday evening: the names heating up on weekend chatter before they hit this board, scored against their filings. Plus Friday receipts: how every score aged, wins and misses. Free, in your inbox.